-transparent.png){kind=logo}
Two adults and two children with life-threatening asthma refractory to maximal standard therapy were treated with the inhalational anesthetic agent isoflurane. In each case, the temporal response to the initiation of therapy was striking. All patients survived and none experienced adverse reactions attributable to the drug. Rapid therapeutic benefit, minimal side effects, absence of cumulative toxicity, and ease of administration are factors supporting the use of isoflurane for patients with severe asthma.
Related Publications
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
June 2006,
Intensive care medicine,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
July 2000,
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
January 2005,
Arerugi = [Allergy],
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
April 1980,
Comprehensive therapy,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
September 1986,
Critical care medicine,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
April 1969,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
October 2023,
The Journal of asthma : official journal of the Association for the Care of Asthma,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
February 1987,
Anesthesia and analgesia,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
January 1993,
Masui. The Japanese journal of anesthesiology,
R G Johnston, and
T W Noseworthy, and
E G Friesen, and
H A Yule, and
A Shustack
April 1991,
Annals of allergy,
